Cronos Group Inc (NASDAQ:CRON) does about 2.83M shares in volume on a normal day but saw 3582807 shares change hands in Monday trading. The company now has a market cap of 1.03B USD. Its current market price is $2.70, marking an increase of 0.75% compared to the previous close of $2.68. The 52 week high reached by this stock is $2.99 whilst the lowest price level in 52 weeks is $1.64.
Cronos Group Inc (CRON) has a 20-day trading average at $2.43 and the current price is -9.70% off the 52-week high compared with 64.63% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.24 and its 200-day simple moving average is $2.03. If we look at the stock’s price movements over the week, volatility stands at 8.20%, which decreases to 6.76% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 63.02 to suggest the stock is neutral.
The consensus objective for the share price is $2.76, suggesting that the stock has a potential upside of 2.17% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on November 02, 2022 when Bernstein initiated the stock to “Mkt Perform” and issued a price target of $3.
Cronos Group Inc (CRON) stock is up 2.27% over the week and 37.06% over the past month. Its price is 29.19% year-to-date and 47.54% over the past year.
The stock last released its quarterly earnings report for quarter ended 12/30/2023, with the company’s earnings per share (EPS) of -$0.05 below consensus estimates by -$0.04. CRON’s earnings per share are forecast to grow by 27.30% this year and 25.00% over next year. Expected sales for next quarter are $24.5 million, which analysts say will come at $100.98 million for the current fiscal year and next year at $120.24 million. In addition, estimates put the company’s current quarterly revenue at an average of $23.78 million.
To reach the target analysts have set, the stock logically needs to grow 2.17 percent from here.
Outstanding shares total 381.30M with insiders holding 46.65% of the shares and institutional holders owning 13.13% of the company’s common stock. The company has a return on investment of -6.71% and return on equity of -6.34%. The forward price to earnings ratio is 135.20. The beta has a value of 1.17. Price to book ratio is 0.94 and price to sales ratio is 11.71.
